GlassScriptPhysician profile
Jacob P Britt
NPI 1275092983
$13,705.19
in general payments reported to CMS, 2019-2025
29 companies · $1,513 in 2025
The $1,513 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $510 · 2020: $328 · 2021: $18.74 · 2022: $135 · 2023: $5,139 · 2024: $6,061 · 2025: $1,513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,304 · Travel and Lodging: $4,199 · Education: $153 · Entertainment: $56.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,303.96 |
| Travel and Lodging | $4,198.97 |
| Education | $153.14 |
| Entertainment | $56.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $6,228.77 | 2020-2025 | Titan, Speedicath |
| Boston Scientific Corporation | $3,777.16 | 2019-2025 | Ams 700, Tactra, Spaceoar Vue System - 10ml |
| Angiodynamics, INC. | $1,159.43 | 2023 | Nanoknife |
| Baxter Healthcare | $390.86 | 2021-2024 | Floseal, Tisseel |
| Janssen Biotech, INC. | $293.90 | 2023-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $278.20 | 2024-2025 | Gemtesa |
| Axonics, INC. | $251.06 | 2023-2024 | Bulkamid, Axonics |
| Medtronic USA, INC. | $176.01 | 2019 | |
| Teleflex LLC | $175.09 | 2024 | Urolift |
| Endo USA, INC. | $124.23 | 2024-2025 | Xiaflex |
| Travere Therapeutics, INC. | $122.32 | 2020 | |
| Edap Technomed INC | $92.93 | 2024-2025 | |
| Ambu INC. | $91.38 | 2023 | |
| Karl Storz Endoscopy-America | $87.60 | 2022 | |
| Medtronic, INC. | $79.60 | 2024-2025 | Interstim |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $47.85 | 2025 | Itind System, Olympus |
| Photocure INC | $47.73 | 2022 | |
| Pfizer INC. | $37.47 | 2025 | |
| Immunitybio, INC. | $37.29 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Civco Medical Instruments | $24.98 | 2025 | |
| Progenics Pharmaceuticals, INC. | $19.64 | 2025 | |
| Tolmar, INC. | $19.44 | 2024 | |
| Kerecis Limited | $19.29 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Urogen Pharma, INC. | $19.17 | 2025 | |
| Antares Pharma, INC. | $18.76 | 2025 | Xyosted |
| Merck Sharp & Dohme LLC | $18.09 | 2024 | Welireg |
| Integra Lifesciences Corporation | $16.43 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Calyxo, INC. | $15.45 | 2024 | Cvac Aspiration System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Britt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.